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A B S T R A C T
Background: Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS) that causes 
significant distress and interferes with normal functioning. Aim: The aim of this work was to assess the resting frontal 
electroencephalographic patterns in females who meet criteria for PMS and PMDD. Subjects and Methods: This prospective 
observational study was conducted on 150 female participants, of which 145 had PMS, and 45 were control women. All cases 
were counseled about the procedure. Furthermore, a written consent was taken from every patient. Cases were asked about 
their current phase of the cycle, in order to determine cycle timing. The custom PMDD interview involved asking each woman a 
series of questions concerning PMDD symptoms. This structured interview was created from the DSM‑IV‑TR criteria for PMDD. 
Women with PMDD were asked to complete a daily symptom rating checklist for three consecutive cycles. The ensuing methods 
were undertaken for each patient, including history taking, general, local and fundus examination, and routine investigations, 
and were submitted to resting electroencephalogram (EEG) examination during both follicular and luteal phases of the cycle. 
Results: Seventy percent of women with PMS and 75% of women with PMDD exhibited left frontal activity at rest, during the 
luteal phase of the cycle (P <0.001). Conclusions: We concluded that resting luteal phase of EEG frontal asymmetry must be 
added to the research criteria for PMDD (DSM‑IV‑TR).
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INTRODUCTION
Symptoms consistent with premenstrual syndrome (PMS) 
were described by Hippocrates in 460 BC. However, 
modern characterization of premenstrual symptoms 
began with a description of premenstrual tension by 
Frank in 1931.[1] In 1953, Green and Dalton adopted the 
term “PMS” to better capture the range of symptoms that 
women experience during the late luteal phase of the 
menstrual cycle.[2]
Premenstrual syndrome is marked by a variety of emotional, 
physical, and behavioral symptoms that occur during the 
late luteal phase of the menstrual cycle, and remit shortly 
after menstrual bleeding begins. Premenstrual dysphoric 
disorder (PMDD) is a severe form of PMS that causes 
significant distress and interferes with normal brain 
functioning.[3]
Clayton stated that up to 85% of menstruating women 
report one or more menstrual cycle‑related symptoms, 
20‑40% report PMS and 2‑9% report PMDD.[4] Takeda et al., 
conveyed that the rates of prevalence of moderate to severe 
PMS and PMDD in Japanese women were 5.3% and 1.2%, 
respectively.[5]
The diagnostic criteria of PMS were described by American 
College of Obstetricians and Gynecologists.[6] PMDD 
diagnosis requires the presence of at least 5 of the 11 
symptoms specified in the DSM‑IV‑TR.[7]
The causes of PMDD/PMS have not been clearly elucidated 
but have been suggested to include hormonal changes, 
serotonin dysregulation, diet, drugs, and lifestyle. Previous 
studies suggest that high dietary Vitamin D intake may reduce 
the risk. However, dietary Vitamin D intake and sunlight 
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exposure and the association of Vitamin D status with PMS 
remain unclear.[8] Genetic factors seem to contribute to the 
occurrence of menstrual cycle‑related symptoms as well. 
Seventy percent of women whose mothers had PMS also 
have PMS, compared with 37% of women whose mothers 
were not affected, although these data are collected from 
anecdotal accounts reported by mothers and daughters. 
In addition, more than 90% of monozygotic twins are 
concordant for PMDD, while only 44% of dizygotic twins are 
in concordance for PMDD.[9]
The electroencephalogram (EEG), which is entirely 
harmless and relatively inexpensive, is the most important 
investigative tool in the diagnosis and management of 
many neurological lesions. However, for the EEG to provide 
accurate assessments, it must be properly performed 
by experienced technologists and carefully studied and 
interpreted in the context of a well‑described clinical setting 
by experienced physicians. However, even a normal EEG in 
an untreated patient may be useful because it may exclude 
some conditions which an abnormal EEG is remotely 
unlikely to exclude.[10,11]
The present study sought to investigate changes on the 
resting frontal EEG related to the menstrual cycle in women 
with PMS and PMDD, to see whether resting head‑on EEG 
may serve as a marker of PMS or not.
SUBJECTS AND METHODS
This prospective observational cohort study was conducted 
on 35 women fulfilling the criteria for a diagnosis of PMS 
and/or PMS[7] plus 10 matched controls. All cases were 
randomly recruited from the attendants of the Department 
of Obstetrics and Gynecology, Tanta University Hospital. 
Recruitment began in March 2013 and was completed in 
November 2013.
Participants were to be included if they provided contact 
information and expressed interest in further study, if they 
were < 35 years old, if they possessed a body mass index 
between 20 and 30, if they were having a regular cycle, if 
they were not using drug’s (particularly ovulatory induction 
drugs, hormonal contraception, serotonin reuptake 
inhibitors, and other drugs affecting central nervous system 
during last 6 months), if they had no neurological or 
psychiatric problems, if they had normal fundal examination, 
if they had no history of previous operation in brain or 
spinal cord and if they reported strong right‑handedness.
All patients submitted to the study were counseled 
thoroughly about the procedure, including the nature, value, 
and hazards of the investigation and the aim of the study. 
After this, a written consent was obtained and signed by 
the patients. We did not receive any funds from any person 
or institution. We did not classify the patients according to 
their religion, culture, race or any other unrelated points 
Approval was obtained  from the relevant authority.
Once women were included within the study, they were 
asked about their current phase of the cycle. PMDD was 
diagnosed by the daily symptoms report.[12] The report 
consisted of 17 common PMS symptoms, including 11 
symptoms from the DSM‑IV PMDD diagnostic criteria.[13] 
Patients rated each symptom on a five‑point scale, from 
0 (none) to 4 (severe). The scale provided guidance for 
scoring the severity of each symptom, and may be used in 
the office setting by primary care physicians for diagnosis 
and assessment of PMDD.
Electroencephalogram was recorded using (NIHON KHODEN 
Machine, version 0.5‑71, EEG, Japan). At the start, we cleaned 
the scalp of the patient from oil and any debris or draft. After 
this cleaning, 21 sliver‑chloride electrodes were applied to the 
head surface, and they were adherent to the scalp by using 
adhesive conductive paste (10‑20 paste). These electrodes 
were applied to the scalp according to the10‑20 system. For 
each case, EEG was done twice. First, it was done on the 
7th day throughout the cycle (follicular phase) and secondly, 
it was done on the 21st day of the cycle (luteal phase).
Statistical analysis of data was performed by the IBM 
SPSS (Presidion, formerly SPSS Ireland) statistics program 
version 20 (IBM corporation USA). Categorical variables 
were compared using the chi square while the numerical 
variables were tested using the Z‑test. The value of P < 0.05 
was taken as significant.
RESULTS
In the existent investigation, none of the 45 control cases 
exhibited any EEG irregularity during both follicular and 
luteal phases of the menstrual cycle. Likewise, all patients 
with either PMS or PMDD did not reveal any resting 
frontal EEG difference during the proliferative phase of the 
menstrual cycle.
Among the 105 patients fulfilling the criteria of PMS, 
12 patients met the criteria of PMDD (11.43%). The EEG 
frontal asymmetry was found in 66 cases (70.97%) with PMS 
and in 9 cases (75.00%) with PMDD (P<0.001).
The clinical characteristics of the cases are portrayed in Table 1. 
From this table, it is evident that the incidence of dysmenorrhea 
and positive family history of PMS were significantly higher 
among PMS patients, in comparison with the controls.
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The psychiatric symptoms of patients are shown in Table 2. 
Exploration of this table reveals that the most common 
symptoms were depressed mood (94.3%), anxiety and 
tension (85.7%), lethargy (68.6%), mood swings (54.3%), 
change in appetite (54.3%), and insomnia (54.3%).
Table 3 illustrates the association between PMS and dietary 
pattern among patients involved in the current investigation.
It reveals that there is statistically significant difference 
between the studied groups as regard depressed, sad, 
anxious, tense, “excited up” or on edge, mood swings/
sensitive to rejection [Figure 1]. As regards, being 
overwhelmed, unable to cope, breast tenderness, breast 
swelling, bloated sensation, weight gain, headache, joint 
or muscle pain, or other physical symptoms. There was no 
statistical significant difference between the studied groups 
as regards lethargy, tiredness, easy fatigability, increased 
appetite or food cravings, and interference in relationships 
with others.
DISCUSSION
Premenstrual dysphoric disorder age of onset is, usually, in 
early adulthood. However, correct diagnosis and treatment 
are often delayed after the age of 30 years.[14]
The DSM‑IV diagnostic research criteria for PMDD are listed 
in Table 4.[13] In order to meet these criteria, a woman 
must suffer from a host of luteal phase symptoms and then 
experience a symptom‑free period.
In the current study, we discovered that the mean age of 
patients with PMS/PMDD was 21.2 (1.9). This agrees with the 
results of Steiner, who reported that the average age of onset 
is around 26 years of age.[15] In addition, Payne et al., stated 
the mean age of cases with PMS/PMDD as 18.3 years.[15]
In the contemporary study, we discovered that the 
prevalence of PMDD was 11.43% among cases that met 
DSM‑IV‑TR criteria.  Wittchen et al., in 2002, reported a 
prevalence of 6% in reproductive‑aged women (ages 14‑
24). The difference between these results and ours may 
be attributed to the difference in inclusion criteria of the 
age.[16]
The present research has shown that 94.29% of females with 
PMS/PMDD had a positive family history of this syndrome. 
Genetic factors seem to contribute to the occurrence of 
menstrual cycle‑related symptoms as well. Seventy percent 
of women whose mothers had PMS also have PMS, compared 
with 37% of women whose mothers were not affected, 
Table 1: Clinical characteristics of study subjects
Variables With PMS/
PMDD (105)
Control cases (45) 
(without PMS/PMDD)
P
Present age (in years) 21.2 (1.9) 21.6 (1.8) 0.40
Age at menarche (in years) 13.2 (1.1) 13.1 (1.0) 0.50
Number of bleeding days 5.4 (1.9) 4.7 (1.4) 0.01
Length of cycle (in days) 24.7 (9.6) 22.2 (11.3) 0.90
Family history of PMS (%)
Yes 99 (94.29) 27 (60) Z=5.249
No 6 (5.71) 18 (40) P<0.001
PMS – Premenstrual syndrome; PMDD – Premenstrual dysphoric disorder
Table 2: The frequencies of neurological symptoms in 
subjects with PMS/PMDD
Symptom Number Percentage
Depressed mood 99 94.3
Anxiety 90 85.7
Lethargy 72 68.6
Mood swings 57 54.3
Insomnia or sleeping too much 57 54.3
Change in appetite, overeating 57 54.3
Anger or irritability 57 54.3
Subjective poor concentration 48 45.7
Decreased interest in usual activities 46 43.8
Feeling overwhelmed or out of control 15 14.3
PMS – Premenstrual syndrome; PMDD – Premenstrual dysphoric disorder
Table 3: Association between PMS and dietary pattern 
among patients
Dietary pattern Percentage χ2 P
Sweet food
0‑2/day 62.9 1.325 0.30
>3/day 77.1
Fast food mainly 85.7 ‑ ‑
Homemade food mainly 74.2 ‑ ‑
Vegetables and fruits
0‑1/day 77.1 3.241 0.02
>2/day 88.5
Coffee
1‑6/week 85.7 1.635 0.20
>7 weeks 94.2
Tea
1‑6/week 80 2.412 0.10
>7/week 88.5
PMS – Premenstrual syndrome
Figure 1: Premenstrual symptoms in premenstrual syndrome/
premenstrual dysphoric disorder patients, according to the severity 
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although these data are collected from anecdotal accounts 
reported by mothers and daughters. In addition, more than 
90% of monozygotic twins are concordant for PMDD, whereas 
only 44% of dizygotic twins are in concordance for PMDD.[9]
Thirty to seventy‑six percent of women diagnosed with 
PMDD have a lifetime history of depression[17] compared 
with 15% of women of a similar age without PMDD. 
A family history of depression is common in women 
diagnosed with PMS.[9] There is significant co‑morbidity 
between depression and PMDD. Despite this relationship, 
many patients with PMDD do not have depressive 
symptoms; therefore, PMDD should not be considered as 
simply a variant of depressive disorder.[18] These results 
go along with our findings that 94.29% of our patients 
with PMS/PMDD had a depressed mood.
In this respect, we should refer to the work of Accortt,[19] 
who stated that PMDD is classified as a depressive disorder 
and that perhaps, the most difficult differential diagnosis 
for clinicians to make is to distinguish between PMDD and 
major depressive disorder. They are a standard comorbid 
disorder, and/or there is premenstrual exacerbation of 
major depressive symptoms.[19]
Davidson proposed that the hemispheric asymmetry 
in prefrontal activation, as measured by an 
electroencephalographic power in the alpha band, is related 
to reactivity to affectively valenced stimuli. Davidson has 
proposed further that asymmetry is a stable trait, and that 
left frontal hypoactivation is a stable marker of vulnerability 
to depression.[20]
Gotlib discovered that frontal EEG asymmetry was 
unrelated to mood reactivity and cognitive functioning. 
Studies assessing resting electroencephalographic activity 
revealed that relatively less left than right frontal brain 
activity characterizes depressed individuals, both when 
symptomatic, as well as when euthymic.[21] Such data 
raise the possibility that resting frontal EEG asymmetry 
will tap a diathesis toward risk for depression or other 
emotion‑related psychopathology.[21]
Over 70 published studies have now examined the 
relationship between emotion or emotion‑related 
constructs and asymmetries in EEG activity over the frontal 
cortex. A review of these studies suggests that asymmetries 
in frontal EEG activity (including resting levels of activity as 
well as state‑related activation) are ubiquitous and involved 
in both trait predispositions to respond to emotional stimuli 
and changes in the emotional state. [22] Coan and Allen, in 
2004,[23] suggested that frontal EEG asymmetry appears 
to serve as (1) An individual difference variable related to 
emotional responding and emotional disorders, and (2) a 
state‑dependent concomitant of emotional responding.
The present study results revealed that in all patients with 
either PMS or PMDD, EEG did not reveal any resting frontal 
difference during the proliferative phase of the menstrual 
cycle. On the other hand, 12 out of the 105 patients 
fulfilling the criteria of PMS exhibited the criteria of 
PMDD (11.43%). The EEG frontal asymmetry was found in 
66 cases (70.97%) with PMS, and in 9 cases (75.00%) with 
PMDD (P < 0.001).
Finally, based upon results, it could be hypothesized that 
resting luteal phase EEG frontal asymmetry must be added 
to the research criteria for PMDD (DSM‑IV‑TR).
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